Delivery Order SPE2DB20D1051-SPE2DB25FD9JD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets (1,000 count) under a firm fixed price contract valued at $1,793.20. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and represents a competitively awarded, non-set-aside procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Metformin HCL ER 500 mg tablets in quantities of 1,000 units, with a ceiling value of $2,509.92. This competitively awarded, non-set-aside contract employs firm fixed pricing and is scheduled for ultimate completion on September 10, 2025. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,513.21 to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets in quantities of 1,000 units. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, issued one day prior on August 28, 2025. The award was made on a competitive basis with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Metformin HCL ER 500 mg tablets in quantities of 1,000 units, with a ceiling value of $1,190.00. This competitively awarded, firm fixed-price delivery order will be fulfilled at the contractor's Conshohocken, Pennsylvania location and is scheduled for completion by July 31, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Metformin ER 500mg tablets (90-count supply) valued at $1,425.60 under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order was issued on September 2, 2025, with an ultimate completion date of the same day, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Metformin is a first-line diabetes...
- The Defense Logistics Agency awarded a $1,250.16 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Metformin HCL ER 500 mg tablets (180-count units). This competitively awarded, firm fixed-price contract is classified as a child award under a larger indefinite delivery contract vehicle and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of September 3, 2025. The contract represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $1,102.08 to AmerisourceBergen Drug Corp for the supply of Metformin HCL 500 mg tablets in quantities of 1,000 units. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award through open procurement. Performance is scheduled for completion by August 21, 2025, with the product to be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a $1,102.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Metformin HCL 500 mg tablets (1000-count units). This non-set-aside contract was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,825.69 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,179,958 tablets of Metformin HCl ER 500 mg. This delivery order was issued under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a delivery order valued at $272.06 to provide 4562251449 metformin HCL ER 500 mg tablets (360 count) under a firm fixed price contract. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day from September 20th through September 21st, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for metformin tablets...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD9JDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Metformin HCL ER 500 mg tablets (1,000 count) with a ceiling value of $2,523.13. The award, made on September 9, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 10, 2025. This order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999.99 billion and extending through December 2026. The IDC enables AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current order for this generic diabetes medication reflects the routine fulfillment of pharmaceutical needs through this strategic contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/9/25 |